A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs
Urfer S.R., Kaeberlein T.L., Mailheau S. et al. · GeroScience, 2017
Ten weeks of low-dose rapamycin in healthy middle-aged dogs was well tolerated, with no significant increase in adverse events over placebo. Echocardiography showed improvements in age-associated measures of heart function.
- Species
- Dogs
- Design
- Randomized controlled trial
- Sample
- 24 middle-aged companion dogs
